Skip to main content
Clinical Trials/PACTR201712002887266
PACTR201712002887266Not yet recruiting未知

Randomized trial to compare Magnesium Sulphate administration for preeclampsia and eclampsia: Springfusor versus standard approach

Not provided0 sites482 target enrollmentStarted: December 18, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
482

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 Year(s) to 48 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1.Pregnant women 20+ weeks of gestation or delivered within 24 hours,
  • 2. diagnosed with preeclampsia and eclampsia i.e. have a raised blood pressure (systolic of >140 mmHg and diastolic > 90mmHg), proteinuria >1+.
  • 3. Present within the study period
  • 4. consent to participate in the study.

Exclusion Criteria

  • 1. Had received magnesium sulphate 24 hours prior to admission,
  • 2) has known allergy to magnesium sulphate
  • 3) elevated serum creatinine (>1.2 mg/dl).

Investigators

Sponsor
Not provided

Similar Trials